Lantern Pharma Inc. Operating Lease Right-of-Use Assets
Lantern Pharma Inc. (LTRN) had Operating Lease Right-of-Use Assets of $38.24 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $38.24K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $56.87K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $75.59K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $93.09K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $38.24K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $56.87K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $75.59K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $93.09K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $143.24K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $192.20K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $239.99K 10-K · filed 2026-03-30 |
| 2024-09-30 | $286.63K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $213.04K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $187.21K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $228.29K 10-K · filed 2026-03-30 |
| 2023-09-30 | $268.64K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $308.25K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $255.32K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $47.69K 10-K · filed 2025-03-27 |
| 2022-09-30 | $82.92K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $117.70K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $152.03K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $185.94K 10-K · filed 2024-03-18 |
| 2021-09-30 | $219.43K 10-Q · filed 2021-11-01 |
| 2021-06-30 | $252.50K 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |